Clinicopathological and EBV analysis of respiratory epithelial adenomatoid hamartoma
© Hua et al.; licensee BioMed Central Ltd. 2014
Received: 6 January 2014
Accepted: 13 March 2014
Published: 25 March 2014
To investigate the clinicopathological characteristics of respiratory epithelial adenomatoid hamartoma (REAH) in residents of Southern China and to study the correlation between REAH and Epstein-Barr virus (EBV).
Clinicopathological data of 53 cases of REAH were retrospectively analyzed. The immunoreactivity for CK 7, CK20, CEA, p53, and Ki-67, Alcian blue–periodic acid-Schiff (AB-PAS) staining and in situ hybridization for EBV-encoded RNA (EBER) were carried out.
REAH lesions were covered with ciliated columnar epithelium and proliferation of subepithelial glands, which were positive for CK7, and negative for CK20, CEA, and p53. Goblet cell metaplasia was stained blue by AB-PAS. The frequency of EBER positive cases in REAH located in nasopharynx was 27.78%, compared with that in the nasal cavity (15.79%) and paranasal sinuses (12.50%), there were no statistical differences.
REAH is an uncommon entity with distinctive morphologic features and EBV may have nothing to do with REAH.
The virtual slide(s) for this article can be found here:
The term "hamartoma" was introduced by Albrecht in 1904 to distinguish between true neoplasms and tumor-like lesions. In 1934, Goldsworthy applied this term to a benign tumor in the lung composed predominantly of a combination of fat and cartilage. This term is now used to designate a focal overgrowth of mature normal cells and tissues at sites of identical cellular composition; thus, a hamartoma may occur in any organ. It may arise from any of the germ layers and does not metastasize. Although hamartomas have been described as occurring throughout the body, they are rare in the upper aerodigestive tract. Respiratory epithelial adenomatoid hamartoma (REAH) was first described in 1995 by Wenig and Heffner in a series of 31 cases. REAH is a benign entity characterized by an abnormal proliferation of glandular tissue surrounded by a thick eosinophilic basement membrane within ciliated respiratory epithelium with no evidence of atypical or metaplastic changes in the squamous cells.
To date, there is limited literature regarding REAH. In particular, no studies of REAH have been carried out in Cantonese individuals living in the central region of Guangdong Province in Southern China. Nasopharyngeal carcinoma (NPC) is common among the Cantonese, and Epstein-Barr virus (EBV) has been considered crucial for NPC cloning. In the current study, we analyzed the clinicopathological characteristics of REAH in residents of Southern China and the correlation between EBV and REAH.
Materials and methods
This study was carried out according to the principles of the Declaration of Helsinki and approved by the Institutional Review Board of the Fourth Affiliated Hospital of Jinan University and Nanfang Hospital of Southern Medical University. All patients provided written informed consent for the collection of samples and subsequent analysis.
The medical records of all 53 patients who were diagnosed with REAH between January 1998 and May 2011 were analyzed. Demographic and clinical data were obtained retrospectively from their hospital medical records, and paraffin-embedded tissue samples and slides were obtained from the Department of Pathology at the Fourth Affiliated Hospital of Jinan University and Nanfang Hospital of Southern Medical University in Guangzhou, China. All patients data and samples were anonymized before use. All of the slides were independently reviewed by five experienced pathologists to reach a diagnosis by consensus.
Immunohistochemistry and AB-PAS histochemical staining
Ten sections, each 4 μm in thickness, were cut from the paraffin blocks of the REAH lesions. Consecutive sections were used to make an optimal comparison between morphology and protein expression. Immunohistochemical staining for cytokeratin (CK) 7, carcinoembryonic antigen (CEA), 34βE12, p63, p53, and Ki-67 was carried out as described elsewhere. Primary antibodies against CK7 (clone OV-TL 12/30, 1:100 dilution), CEA (clone Ks20.8, 1:50 dilution), Collagen IV(clone PHM-12, 1:100 dilution), p63 (clone 4A4, 1:200 dilution), p53 (clone DO-7, 1:100 dilution), and Ki-67 (clone MIB-1, 1:25 dilution) were obtained from Dako Corporation (Glostrop, Denmark). Appropriate positive and negative controls were run in each case. As negative staining controls, the primary antibodies were replaced with the primary antibody diluents.
Alcian blue–periodic acid-Schiff (AB-PAS) staining was carried out by immersing each section in a solution of alcian blue and 3% acetic acid for 30 min, then in Schiff’s reagent for 15 min to promote oxidation, and then counterstaining it in hematoxylin.
In situ hybridization for EBER
To determine the correlation between EBV and REAH, we divided our tissue samples into 4 groups: Group 1 consisted of normal tissue from the nasal cavity and paranasal sinuses mucosa (31 samples); group 2 consisted of REAH tissue taken from the same structures (31 samples); group 3 consisted of normal mucosal tissue from the nasopharynx (22 samples); and group 4 consisted of REAH tissue taken from the nasopharynx (22 samples).
In situ hybridization was performed using a flourescein-conjugated EBV peptide nucleic acid (PNA) probe (Dako) for EBV-encoded RNA (EBER) according to the manufacturer’s instructions. After the sections were dewaxed, they were rehydrated in graded alcohol and distilled water and predigested with proteinase K. A hybridization solution containing the fluorescein-conjugated EBV nucleic acid probe was then applied, followed by the application of alkaline-phosphatase–conjugated antibody to fluorescein isothiocyanate. Bromochloroindolyl phosphate/nitro blue tetrazolium chloride (BCIP/NBT) combined with levamisole was applied to serve as the chromogen. The slides were then lightly counterstained with hematoxylin. Dark blue or black staining of the nucleus served as a signal of hybridization. Positive and negative control slides were run for each specimen by replacing the EBV probe with a positive or negative fluorescein-conjugated PNA probe (Dako).
The staining results of EBERs in REAH tissues were analyzed using Fisher’s exact test in comparison with that of control group obtained from corresponding normal tissue. p value of less than 0.05 was considered significant.
Number of cases
Chronic recurrent sinusitis
Immunohistochemistry and histochemical staining
EBER in situ hybridization
EBV-encoded small RNAs staining in REAH and corresponding normal tissues
Positively stained for EBERs
REAH is an expansile mass that causes upper respiratory symptoms and discomfort mainly in adults. Symptoms at presentation vary and are similar to those that accompany chronic sinusitis, eg, nasal congestion, nasal obstruction, headaches, facial pain, epistaxis, and hyposmia. Endoscopy does not reveal any distinguishing features to suggest a diagnosis of REAH, and neither CT nor magnetic resonance imaging produces a specific signal intensity that can help the clinician distinguish REAH from other sinus lesions[3, 8, 9]. Distinctive histologic features of REAH include a glandular component that originates in the overlying surface respiratory epithelium and polypoid growths that represent a proliferation of respiratory epithelial adenomatoid tissue. It is important to recognize this lesion, however, because it can be confused histopathologically with other disease processes that require a significantly different treatment approach. Included in the microscopic differential diagnosis of REAH are inflammatory polyps[4, 9, 10], inverted Schneiderian papillomas[3, 4, 10, 11], and well-differentiated adenocarcinoma[3, 11]. Pathologists must be aware of this entity to avoid overdiagnosis and overly aggressive surgical procedures.
Mucins are conventionally classified as neutral mucins or acid mucins (the latter comprising sulfomucins and sialomucins) according to the color reaction obtained with histochemical stains such as periodic acid–Schiff (PAS) and Alcian blue (AB) at pH 2.5. Airway mucins are produced by two different types of cells: goblet cells in the surface epithelium and mucous cells in submucosal glands. In our study, more mucins took up the blue AB-PAS stain in REAH tissue than in controls. This suggests that REAH-associated metaplasia develops predominantly in the goblet cells in ciliated respiratory epithelial tissue and that acid mucin production is increased in the airways of patients with this disease.
Mucus protects the underlying airway epithelium from dehydration and from damage by pathogens or chemical and particulate irritants[13, 14]. It has been proposed that an abnormal increase in mucus secretion promotes bacterial adhesion and inhibits bacterial clearance by impeding cilial function[15, 16], which may exacerbate symptoms in patients with REAH.
REAH is frequently associated with inflammatory polyps, although it has been suggested that these polyps arise secondary to the inflammatory process. The mechanisms responsible for inducing REAH are still unknown.
To date, there has been only one study of the molecular genetics of REAH. Ozolek and Hunt showed that patients with REAH lack heterozygosity for loci on chromosomes 9p and 18q and exhibit a fractional allelic loss of 31%, which the authors concluded was unusually high for a nonneoplastic entity. They suggested that REAH may, in fact, be a benign neoplasm and not a hamartoma, as was originally believed. In our study, the nuclear features of REAH were bland and both epithelial components and basal cells were negative for p53. Ki-67 staining was only localized to the basal layer and the labeling index less than 1%. These findings support the benign nature of the lesion.
REAH is a rare lesion that is limited to the nasal cavity, paranasal sinuses, and nasopharynx. Wenig and Heffner estimated that approximately 70% of REAH tissue is in the nasal cavity and 9.68% is in the nasopharynx. However, our data, suggest that 35.85% of REAH tissue is in the nasal cavity, 30.19% in the paranasanl sinuses and 33.96% in the nasopharynx.
NPC is a nonlymphomatous squamous-cell carcinoma that arises in the epithelial lining of the nasopharynx. This neoplasm is uncommon in most countries, with an age-adjusted incidence in both sexes of fewer than 1:100,000. It occurs with much greater frequency in Southern China, however, especially among Chinese people living in the province of Guangdong (25 to 30:100,000 annually)[18–20]. In contrast to other head and neck cancers and to epithelial malignancy in general, NPC is unique in terms of its strong association with EBV, which is consistently detected in patients with NPC, whether they are from regions with a high or low incidence of NPC[21, 22].
The EBER signal has been shown through in situ hybridization to be present in nearly all tumor cells. In NPC cells, EBV exists as an episome and is not integrated into the host genome. EBV adopts a specific form of latent infection, latency II, in NPC cells. Only a limited number of viral gene transcripts—including transcripts for EBER, EBNA1, LMP1, LMP2, BARF1, and several BamHI s—are expressed. A latent EBV infection may take place before expansion of the malignant cell, which would indicate that EBV plays a critical role in transforming nasopharyngeal epithelial cells into an invasive form of cancer[22–24].
In our study, all of the patients were from Guangdong, and most of their REAH lesions were found in the nasopharynx. To the best of our knowledge, ours was the first attempt to study the correlation between EBV and REAH in Southern China.
In situ hybridization has been proven to be a valuable molecular tool for the diagnosis and understanding of viral and neoplastic disease[25, 26]. This test provides optimal DNA detection sensitivity of approximately 40 kb in tissue sections and 10 to 20 copies of mRNA or viral DNA per cell. It is more sensitive to EBER than polymerase chain reaction analysis in the search for EBV latency in tissues and allows for localization of the EBV signal in tumor cells. In situ hybridization of EBER was reported to have a sensitivity of 98% and a specificity of 100% in detecting primary NPC.
The cancer-associated herpesvirus EBV infects more than 90% of the world’s population. Initial infection of EBV in human is usually asymptom or causes mononucleosis syndrome. Several neoplasms have been shown to be associated with EBV as evidenced by the presence of EBV genome in the tumor cells. In our study, EBER was found sporadically positive expressed in some of the obtained tissues. Despite the fact that EBER was detected more frequently in REAH tissue, we found no statistically significant difference in EBV latency among tissues obtained from the nasal cavity, paranasal sinuses, and nasopharynx of patients with REAH or between REAH and normal mucosal tissue. We concluded that EBV may have nothing to do with REAH. These observations lend support the suggestion that REAH is a reactive rather than neoplastic lesion. Further investigation through molecular studies will be essential to further our understanding of the pathogenesis of this disease.
This work was supported by grants from National natural science foundation of China (No.81272849)and Science and technology projects of Guangdong Science and Technology Department (No. 2012B020700005).
- Albrecht E: Ueber hamartome. Verh Dtsch Ges Pathol. 1904, 7: 153-157.Google Scholar
- Goldsworthy NE: Chondroma of lung (hamartoma chondromatosum pulmonis), with report of case. J Pathol Bacterio. 1934, 39: 291-298. 10.1002/path.1700390206.View ArticleGoogle Scholar
- Sangoi AR, Berry G: Respiratory epithelial adenomatoid hamartoma: diagnostic pitfalls with emphasis on differential diagnosis. Adv Anat Patho. 2007, 14: 11-16. 10.1097/PAP.0b013e31802efb1e.View ArticleGoogle Scholar
- Wenig BM, Heffner DK: Respiratory epithelial adenomatoid hamartomas of the sinonasal tract and nasopharynx: a clinicopathologic study of 31 cases. Ann Otol Rhinol Laryngol. 1995, 104: 639-645.PubMedView ArticleGoogle Scholar
- Fitzhugh VA, Mirani N: Respiratory epithelial adenomatoid hamartoma: a review. Head Neck Pathol. 2008, 2: 203-208. 10.1007/s12105-008-0064-3.PubMedPubMed CentralView ArticleGoogle Scholar
- Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995, 333: 693-698. 10.1056/NEJM199509143331103.PubMedView ArticleGoogle Scholar
- Liu W, Tian XY, Li Y, Zhao Y, Li B, Li Z: Coexistence of pulmonary sclerosing hemangioma and primary adenocarcinoma in the same nodule of lung. Diagn Pathol. 2011, 6: 41-10.1186/1746-1596-6-41.PubMedPubMed CentralView ArticleGoogle Scholar
- Ingram WF, Noone MC, Gillespie MB: Respiratory epithelial adenomatoid hamartoma: a case report. Ear, Nose Throat J. 2006, 85: 190-192.Google Scholar
- Delbrouck C: Fernandez Aguilar S, Choufani G, Hassid S: Respiratory epithelial adenomatoid hamartoma associated with nasal polyposis. Am J Otolaryngol. 2004, 25: 282-284. 10.1016/j.amjoto.2004.02.005.PubMedView ArticleGoogle Scholar
- Kessler HP, Unterman B: Respiratory epithelial adenomatoid hamartoma of the maxillary sinus presenting as a periapical radiolucency: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004, 97: 607-612. 10.1016/j.tripleo.2003.09.013.PubMedView ArticleGoogle Scholar
- Munoz G, Felipo F, Marquina I, Del Agua C: Epithelial-myoepithelial tumour of the lung: a case report referring to its molecular histogenesis. Diagn Pathol. 2011, 6: 71-10.1186/1746-1596-6-71.PubMedPubMed CentralView ArticleGoogle Scholar
- Nakanishi K, Tominaga S, Kawai T, Torikata C, Aurues T, Ikeda T: Mucin histochemistry in primary adenocarcinoma of the urinary bladder (of urachal or vesicular origin) and metastatic adenocarcinoma originating in the colorectum. Pathol Int. 2000, 50: 297-303. 10.1046/j.1440-1827.2000.01049.x.PubMedView ArticleGoogle Scholar
- Liote H, Zahm JM, Pierrot D, Puchelle E: Role of mucus and cilia in nasal mucociliary clearance in healthy subjects. Am Rev Respir Dis. 1989, 140: 132-136. 10.1164/ajrccm/140.1.132.PubMedView ArticleGoogle Scholar
- Kalhoff H: Mild dehydration: a risk factor of broncho-pulmonary disorders?. Eur J Clin Nutr. 2003, 57 (Suppl 2): S81-S87.PubMedView ArticleGoogle Scholar
- Lidell ME, Moncada DM, Chadee K, Hansson GC: Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc Natl Acad Sci U S A. 2006, 103: 9298-9303. 10.1073/pnas.0600623103.PubMedPubMed CentralView ArticleGoogle Scholar
- Yoon SS, Hassett DJ: Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets. Expert Rev Anti Infect Ther. 2004, 2: 611-623. 10.1586/1478718.104.22.1681.PubMedView ArticleGoogle Scholar
- Ozolek JA, Hunt JL: Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol. 2006, 30: 1576-1580. 10.1097/01.pas.0000213344.55605.77.PubMedView ArticleGoogle Scholar
- Ruckenstein MJ: Nasopharyngeal Carcinoma. Comprehensive Review of Otolaryngology. Edited by: Ruckenstein MJ. 2004, Philadelphia: W.B.Saundrs, 197-198.Google Scholar
- Wei WI, Sham JST: Nasopharyngeal carcinoma. Lancet. 2005, 365: 2041-2054. 10.1016/S0140-6736(05)66698-6.PubMedView ArticleGoogle Scholar
- Jeyakumar A, Brickman TM, Jeyakumar A, Doerr T: Review of nasopharyngeal carcinoma. Ear Nose Throat J. 2006, 85: 168-170.PubMedGoogle Scholar
- Chong VF, Ong CK: Nasopharyngeal carcinoma. Eur J Radiol. 2008, 66: 437-447. 10.1016/j.ejrad.2008.03.029.PubMedView ArticleGoogle Scholar
- Long HM, Taylor GS: Immune defence against EBV and EBV-associated disease. Curr Opin Immunol. 2011, 23: 258-264. 10.1016/j.coi.2010.12.014.PubMedView ArticleGoogle Scholar
- Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C: Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China. Microbes Infect. 2011, 13: 776-782. 10.1016/j.micinf.2011.04.002.PubMedView ArticleGoogle Scholar
- Cui Y, Wang Y, Liu X, Chao Y, Xing X, Zhao C, Liu C, Luo B: Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Northern China. Intervirology. 2011, 54: 131-138. 10.1159/000319632.PubMedView ArticleGoogle Scholar
- Jin L, Lloyd RV: In situ hybridization: methods and applications. J Clin Lab Anal. 1997, 11: 2-9. 10.1002/(SICI)1098-2825(1997)11:1<2::AID-JCLA2>3.0.CO;2-F.PubMedView ArticleGoogle Scholar
- Morris BJ: In situ hybridization. Methods Mol Biol. 1995, 41: 41-49.PubMedGoogle Scholar
- An Tie H, Ching Liang H, Yeu Chin C, Wei Yau K, Tsu Yi C: Epstein-Barr virus and lymphoid hematological disorders. Chin Med J (Taipei). 2002, 65: 119-Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.